Cargando…
Prasugrel-Based De-Escalation in Patients With Acute Coronary Syndrome According to Renal Function
BACKGROUND: Patients with coronary artery disease and impaired renal function are at higher risk for both bleeding and ischemic adverse events after percutaneous coronary intervention (PCI). OBJECTIVES: This study assessed the efficacy and safety of a prasugrel-based de-escalation strategy in patien...
Autores principales: | Yun, Jun Pil, Kang, Jeehoon, Park, Kyung Woo, Park, Kyungil, Hwang, Doyeon, Han, Jung-Kyu, Yang, Han-Mo, Kang, Hyun-Jae, Koo, Bon-Kwon, Chae, In-Ho, Moon, Keon-Woong, Park, Hyun Woong, Won, Ki-Bum, Jeon, Dong Woon, Han, Kyoo-Rok, Choi, Si Wan, Ryu, Jae Kean, Jeong, Myung Ho, Kim, Hyo-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982221/ https://www.ncbi.nlm.nih.gov/pubmed/36873753 http://dx.doi.org/10.1016/j.jacasi.2022.09.013 |
Ejemplares similares
-
Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI
por: Ki, You-Jeong, et al.
Publicado: (2021) -
Erratum: Correction of Text in the Article “Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI”
por: Ki, You-Jeong, et al.
Publicado: (2022) -
Real-world evidence of switching P2Y12 receptor–inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry
por: Kang, Jeehoon, et al.
Publicado: (2023) -
Angiographic complete revascularization versus incomplete revascularization in patients with diabetes mellitus
por: Hwang, Doyeon, et al.
Publicado: (2022) -
Analysis of Potential Cost-Savings After Introduction of Drug-Eluting Balloon Angioplasty for In-Stent Restenosis or Small Vessel Disease
por: Park, Kyungil, et al.
Publicado: (2011)